Viewing Study NCT05125068

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 5:52 PM
Ignite Modification Date: 2026-01-23 @ 6:35 PM
Study NCT ID: NCT05125068
Status: TERMINATED
Last Update Posted: 2024-03-26
First Post: 2021-11-08
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Safety and Efficacy of AT-1501 in Patients With IgA Nephropathy (IgAN)
Sponsor: Eledon Pharmaceuticals
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None IgA Nephropathy View
None IgAN View
Keywords:

Keywords

Keyword Brief Keyword Text View
None IgA Nephropathy View
None IgAN View
None AT-1501 View
None CD40L View
None Monoclonal antibody View
None Proteinuria View
None eGFR View
None UPCR View